SCHEMBL9549885

SCHEMBL9549885

CN1CCC2CC1N(C)c1c(C=O)cc(O)cc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10591290 0.81 ACHE (0.32)
SCHEMBL9549981 0.81 SIGMAR1 (0.31)
SCHEMBL9550053 0.80 ACHE (0.33)
Acetic Acid SCHEMBL9549945 0.79
SCHEMBL9549900 0.75 KDM4E (0.39)
SCHEMBL9550020 0.68 DRD1 (0.34)
SCHEMBL9549952 0.67 ACHE (0.35)
SCHEMBL9550063 0.66 SIGMAR1 (0.32)
SCHEMBL9549983 0.64 ALDH1A1 (0.38)
SCHEMBL9549940 0.63 ACHE (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5264575-A Reacting 1,3-benzodiazocine-8-ol derivative with lutidine/2,6-/, triisoproylsilyltrifluoro methane, formed intermediate reacted with lithium chloride, tetrabutylammonium fluoride and isocyanate HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1993-11-23 US disclosed
US-5097033-A Aminoethyl quinoline 2-ones, intermediates for analgesic, and cholinergic agents for memory disorders HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-03-17 US disclosed
US-5010083-A Cognition activator; Alzheimer*s disease HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1991-04-23 US disclosed
EP-0335292-A2 2,6-Methano-1,3-benzodiazocines, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-10-04 EP disclosed